Michael Bober
Clinical Genetics (M.D.) · Wilmington, DENPI 1255422531
Payments from drug & device makers
Across 614 payments — averaging $3230.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$1.3M
- Pfizer$218K
- QED Therapeutics, Inc.$204K
- Swedish Orphan Biovitrum AB$114K
- Ultragenyx Pharmaceutical Inc.$57K
- Shire North American Group Inc$37K
- plus $63K from 5 others
What the payments were for
- Consulting fees$25,08134%
- Speaking & faculty fees$30,35542%
- Travel & lodging$12,40817%
- Food & beverage$1,1952%
- Education$4,0386%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 289 | $1,290,330 |
| Pfizer | 27 | $218,093 |
| QED Therapeutics, Inc. | 32 | $204,237 |
| Swedish Orphan Biovitrum AB | 217 | $114,361 |
| Ultragenyx Pharmaceutical Inc. | 18 | $56,780 |
| Shire North American Group Inc | 1 | $37,235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $33,626 |
| Therachon Holding GmbH | 8 | $9,899 |
| AstraZeneca | 11 | $9,725 |
| Ascendis Pharma Endocrinology Inc | 2 | $7,249 |
| Novo Nordisk | 1 | $2,040 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Delawareto place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Wilmington
- Mahim JainWilmington$433K
- Nina Powell-HamiltonWilmington$5K
- Julie KaplanWilmington$393
- Karen GrippWilmington$198
- Bruce BomanNewark$59
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.